Ans Heirman – AVP Managing Director, MSD Switzerland
Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in…
Tagged with Vaccine
IFPMA’s Thomas Cueni on why “#TeamVaccines is all of…
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights the incredible progress of COVID-19…
The bright future of mRNA technology – InConversation…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…
Russia: $7.4 bln for Healthcare Modernisation; Generics Push;…
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…
Vaccines: Manufacturing & Supply Chain Complexity
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…
Vaccines: An Expanded R&D Playbook
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox in 1976 by injecting them with…
Brazilian Pharma: Market Outperforming LatAm, Vaccine…
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in real terms (inflation adjusted),…
Vaccines: Market Model Innovation
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the pharmaceutical industry, vaccines are also…
France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…
Population Health: Access & AntiVax Challenges
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…
5 Top Trends in Chinese Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…
LatAm: Vaccination Challenges; Colombian COVID Variant;…
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national COVID-19 vaccination programs, a…
